Arax Advisory Partners’s ChemoCentryx, Inc. CCXI Stock Holding History

Arax Advisory Partners’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-18	Closed	-$1K	–	1367
2022 Q3	$1K	Sell	18 -17	-49%	-$703	﹤0.01%	1203
2022 Q2	$1K	Buy	35 +7	+25%	+$154	﹤0.01%	1148
2022 Q1	$1K	Buy	28 +14	+100%	+$393	﹤0.01%	1143
2021 Q4	$1K	Buy	+14	New	+$491	﹤0.01%	1126

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Arax Advisory Partners's CCXI Position: Q4 2022 in Review

Arax Advisory Partners sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 18 shares — an estimated $1K sold.

Arax Advisory Partners first reported a position in CCXI in Q4 2021 and held it in 4 quarters. The position peaked at $1K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Arax Advisory Partners reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Arax Advisory Partners sold 18 ChemoCentryx, Inc. shares in Q4 2022, an estimated $1K.
Arax Advisory Partners first reported a position in ChemoCentryx, Inc. in Q4 2021 and held it in 4 quarters.
Arax Advisory Partners's ChemoCentryx, Inc. position peaked at $1K in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Arax Advisory Partners's 13F filing for Q4 2022, filed 24 Feb 2023.